no Phase 3 trials are known to be actively recruiting in the UK as of July 2025
It is essential to discuss these risks with a medical professional to guarantee that the compound tirzepatide is safe and to manage the intricacies related to mixed drugs
Working with a knowledgeable healthcare provider, whether through in-person visits or local peptide therapy clinics or specialized clinics , is strongly recommended for anyone considering either compound
Considering that and -cells express GIPR (224) and that the GIP-potentiating activity of Xenin has been reported to be lost in human diabetics (223), it appears to be a critical player in this disease, likely involving the activity of GLP-1
By treating one aspect of this metabolic syndrome, this will in turn improve the other risk factors for heart disease, which then downstream improves the cardiovascular outcomes
Long-term effects unknown : While the clinical trials look good, the long-term safety and efficacy of tirzepatide, especially for weight loss, is still being studied